Greenhushing: What It Is & Why It Matters
Podcast - Navigating Regulatory Challenges in M&A Transactions
The Demystification of Employee Retention Credits for Private Equity Deals — PE Pathways Podcast
OG Talks: Good Energy and Navigating Transactions
Troutman Pepper Locke - The Powerhouse Merger – The Consumer Finance Podcast
SBA’s Final Rule Is Here: Key Takeaways on Updates to HUBZone Program, Other Small Business Programs, and Various Small Business Matters
Navigating Restrictive Covenants in Private Equity — PE Pathways Podcast
Executive Compensation in Mergers and Acquisitions — Troutman Pepper Podcast
Private M&A 2024: Key Trends and Forecasts
M&A Considerations for Serial Acquirers
Fierce Competition Podcast | Below-Threshold Mergers: Global Antitrust Scrutiny
Best Practices for Preparing Your Company for Exit
JONES DAY TALKS®: Five Pillars of Series A Shareholder Rights: A Discussion for VC Investors
What is Reverse Vesting and What are the Tax Considerations?
What Does "Cash Free / Debt Free" Mean?
How is Purchase Price Established?
What's the Best Transaction Structure for My Sale?
Should You Engage a Financial Advisor?
Implementing IP Best Practices to Maximize Exit Value
What's the Timeline for a Sale Process?
Welcome to the January 2025 edition of the Jenner & Block Japan Newsletter, a publication containing updates about legal developments in the United States that may be noteworthy to our clients and other leaders in the...more
The incoming Trump administration is expected to make several policy changes likely to impact tech transactions. President-elect Donald Trump has promised to reduce regulation and cut federal bureaucracy, which he says have...more
To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more
In March 2021, our experienced intellectual property, antitrust, and health care litigation lawyers shared some predictions on antitrust policy and enforcement in the health care sector. In “Health Care Antitrust under...more
Join the Hogan Lovells Antitrust and Competition team on Friday, March 12, 2021 to discuss hot antitrust topics in the life sciences industry, including: - What life sciences companies should expect with respect to...more
As 2019 kicks off, the Cooley antitrust group highlights 10 recent developments and trends corporate counsel should be aware of – from the US Supreme Court and lower courts, the Department of Justice and Federal Trade...more